COVID-19: Antiplatelet Agents May Reduce Thrombotic Risk ...Middle East

News by : (Medscape) -
Severe COVID-19 patients have sustained platelet activation, likely contributing to thrombotic issues seen with the infection. Antiplatelet therapy such as aspirin may be of benefit, researchers say. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( COVID-19: Antiplatelet Agents May Reduce Thrombotic Risk )

Also on site :

Most Viewed News
جديد الاخبار